These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 27090819

  • 1. Phase shifts to light are altered by antagonists to neuropeptide receptors.
    Chan RK, Sterniczuk R, Enkhbold Y, Jeffers RT, Basu P, Duong B, Chow SL, Smith VM, Antle MC.
    Neuroscience; 2016 Jul 07; 327():115-24. PubMed ID: 27090819
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gastrin-releasing peptide mediates light-like resetting of the suprachiasmatic nucleus circadian pacemaker through cAMP response element-binding protein and Per1 activation.
    Gamble KL, Allen GC, Zhou T, McMahon DG.
    J Neurosci; 2007 Oct 31; 27(44):12078-87. PubMed ID: 17978049
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
    Reed HE, Meyer-Spasche A, Cutler DJ, Coen CW, Piggins HD.
    Eur J Neurosci; 2001 Feb 31; 13(4):839-43. PubMed ID: 11207820
    [Abstract] [Full Text] [Related]

  • 6. Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    Kallingal GJ, Mintz EM.
    Eur J Neurosci; 2006 Nov 31; 24(10):2853-8. PubMed ID: 17156209
    [Abstract] [Full Text] [Related]

  • 7. Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.
    Dardente H, Menet JS, Challet E, Tournier BB, Pévet P, Masson-Pévet M.
    Brain Res Mol Brain Res; 2004 May 19; 124(2):143-51. PubMed ID: 15135222
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic region.
    Albers HE, Gillespie CF, Babagbemi TO, Huhman KL.
    Neurosci Lett; 1995 May 19; 191(1-2):63-6. PubMed ID: 7659293
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differences in colocalization between Fos and PHI, GRP, VIP and VP in neurons of the rat suprachiasmatic nucleus after a light stimulus during the phase delay versus the phase advance period of the night.
    Romijn HJ, Sluiter AA, Pool CW, Wortel J, Buijs RM.
    J Comp Neurol; 1996 Aug 12; 372(1):1-8. PubMed ID: 8841917
    [Abstract] [Full Text] [Related]

  • 17. Gastrin-releasing peptide mediates photic entrainable signals to dorsal subsets of suprachiasmatic nucleus via induction of Period gene in mice.
    Aida R, Moriya T, Araki M, Akiyama M, Wada K, Wada E, Shibata S.
    Mol Pharmacol; 2002 Jan 12; 61(1):26-34. PubMed ID: 11752203
    [Abstract] [Full Text] [Related]

  • 18. Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits.
    Atkins N, Mitchell JW, Romanova EV, Morgan DJ, Cominski TP, Ecker JL, Pintar JE, Sweedler JV, Gillette MU.
    PLoS One; 2010 Sep 07; 5(9):e12612. PubMed ID: 20830308
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus.
    Kallingal GJ, Mintz EM.
    Eur J Neurosci; 2014 Feb 07; 39(4):630-9. PubMed ID: 24528136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.